Quick Answer
ENvue Medical, Inc. reported Research And Development Expense of $909.0 thousand for the year ending 2024.
- ENvue Medical, Inc. showed an increase of +391.4% in Research And Development Expense from 2023 to 2024.
- This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $89.0 thousand | Q3 2014: $101.0 thousand | Q1 2015: $95.0 thousand | Q2 2015: $115.0 thousand | Q3 2015: $87.0 thousand | Q1 2016: $114.0 thousand | Q2 2016: $173.0 thousand | Q3 2016: $161.0 thousand | Q1 2017: $150.0 thousand | Q2 2017: $164.0 thousand | Q3 2017: $160.0 thousand | Q1 2018: $136.0 thousand | Q2 2018: $151.0 thousand | Q3 2018: $121.0 thousand | Q1 2019: $152.0 thousand | Q2 2019: $150.0 thousand | Q3 2019: $79.0 thousand | Q1 2020: $47.0 thousand | Q2 2020: $16.0 thousand | Q3 2020: $68.0 thousand | Q1 2021: $64.0 thousand | Q2 2021: $64.0 thousand | Q3 2021: $50.0 thousand | Q1 2022: $66.0 thousand | Q2 2022: $61.0 thousand | Q3 2022: $49.0 thousand | Q1 2023: $55.0 thousand | Q2 2023: $35.0 thousand | Q3 2023: $33.0 thousand | Q1 2024: $121.0 thousand | Q2 2024: $187.0 thousand | Q3 2024: $249.0 thousand | Q1 2025: $530.0 thousand | Q2 2025: $972.0 thousand | Q3 2025: $221.0 thousand.
- Over the full 11 years of available data (2014 to 2024), ENvue Medical, Inc.'s Research And Development Expense has grown by 110.9%.
- Historical annual values: Fiscal year 2024: $909.0 thousand | Fiscal year 2023: $185.0 thousand | Fiscal year 2022: $283.0 thousand | Fiscal year 2021: $293.0 thousand | Fiscal year 2020: $171.0 thousand | Fiscal year 2019: $514.0 thousand | Fiscal year 2018: $614.0 thousand | Fiscal year 2017: $693.0 thousand | Fiscal year 2016: $584.0 thousand | Fiscal year 2015: $399.0 thousand | Fiscal year 2014: $431.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: